title: RTOG 0522: huge Investment in patients and resources and no benefit with addition of cetuximab to radiotherapy--why did this occur?
authors.affiliation: Washington University School of Medicine, St Louis, MO dadkins@dom.wustl.edu.
authors.forename: Douglas
authors.initials: D
authors.lastname: Adkins
authors.affiliation: Washington University School of Medicine, St Louis, MO.
authors.forename: Jessica
authors.initials: J
authors.lastname: Ley
authors.affiliation: Washington University School of Medicine, St Louis, MO.
authors.forename: Tanya M
authors.initials: TM
authors.lastname: Wildes
authors.affiliation: Washington University School of Medicine, St Louis, MO.
authors.forename: Loren
authors.initials: L
authors.lastname: Michel
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D059248:Chemoradiotherapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D008297:Male